Stocks Comparison
Enigmatig vs Pharma-Bio Serv: revenue, profit, margins and growth compared
Enigmatig brought in $4.5M of revenue in fiscal 2025, Pharma-Bio Serv $9M in fiscal 2025. Revenue changed by +12.2% at Enigmatig and -5.3% at Pharma-Bio Serv on the year before, so Enigmatig grew faster. Enigmatig kept 12.6% of its revenue as net profit, Pharma-Bio Serv -1.1%. Free cash flow was -$2M at Enigmatig and -$221.5K at Pharma-Bio Serv.
Side by side, latest fiscal year
| EGG | PBSV | |
|---|---|---|
| Fiscal year ended | FY2025 (September 30, 2025) | FY2025 (October 31, 2025) |
| Revenue | $4.5M | $9M |
| Revenue growth | +12.2% | -5.3% |
| Net income | $559.7K | -$100.5K |
| Net margin | 12.6% | -1.1% |
| Free cash flow | -$2M | -$221.5K |
| Free cash flow margin | -44.1% | -2.5% |
| Earnings per share (diluted) | $0.02 | -$0.00 |
| Cash | $13.2M | $3.4M |
| Debt | n/a | n/a |
| Price to earnings | n/a | n/a |
| Market value | n/a | $8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #528 of 587 · Industrials | #508 of 587 · Industrials |
Over the years
Questions about Enigmatig and Pharma-Bio Serv
Which is bigger by revenue, Enigmatig or Pharma-Bio Serv?
Pharma-Bio Serv is bigger by revenue: $9M in fiscal 2025, against $4.5M for Enigmatig in fiscal 2025.
Which keeps more of its revenue as profit, Enigmatig or Pharma-Bio Serv?
Enigmatig had a net margin of 12.6% in fiscal 2025; Pharma-Bio Serv had -1.1% in fiscal 2025.
Which grew revenue faster, Enigmatig or Pharma-Bio Serv?
In their latest fiscal years revenue changed by +12.2% at Enigmatig and -5.3% at Pharma-Bio Serv.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.